Dempze Nancy E Cuts Stock Holdings in Colgate-Palmolive (NYSE:CL)

Dempze Nancy E decreased its holdings in shares of Colgate-Palmolive (NYSE:CL) by 11.3% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 5,472 shares of the company’s stock after selling 700 shares during the quarter. Dempze Nancy E’s holdings in Colgate-Palmolive were worth $391,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also modified their holdings of the company. Zeke Capital Advisors LLC boosted its stake in Colgate-Palmolive by 1.3% in the second quarter. Zeke Capital Advisors LLC now owns 62,057 shares of the company’s stock worth $4,448,000 after buying an additional 795 shares in the last quarter. First Quadrant L P CA boosted its stake in Colgate-Palmolive by 265.5% in the second quarter. First Quadrant L P CA now owns 43,131 shares of the company’s stock worth $3,091,000 after buying an additional 31,331 shares in the last quarter. ST Germain D J Co. Inc. boosted its stake in Colgate-Palmolive by 1.0% in the second quarter. ST Germain D J Co. Inc. now owns 16,694 shares of the company’s stock worth $1,196,000 after buying an additional 164 shares in the last quarter. Greenleaf Trust boosted its stake in Colgate-Palmolive by 2.8% in the second quarter. Greenleaf Trust now owns 89,187 shares of the company’s stock worth $6,392,000 after buying an additional 2,468 shares in the last quarter. Finally, Daiwa Securities Group Inc. boosted its stake in Colgate-Palmolive by 2.0% in the second quarter. Daiwa Securities Group Inc. now owns 36,940 shares of the company’s stock worth $2,647,000 after buying an additional 738 shares in the last quarter. 75.52% of the stock is owned by institutional investors.

CL stock traded down $0.06 during midday trading on Friday, hitting $71.20. The company had a trading volume of 3,813,538 shares, compared to its average volume of 3,524,740. The company has a current ratio of 1.13, a quick ratio of 0.78 and a debt-to-equity ratio of 32.25. Colgate-Palmolive has a 52 week low of $57.41 and a 52 week high of $76.41. The firm has a 50 day moving average price of $73.13. The company has a market capitalization of $61.14 billion, a PE ratio of 23.97, a price-to-earnings-growth ratio of 4.59 and a beta of 0.76.

Colgate-Palmolive (NYSE:CL) last announced its quarterly earnings data on Friday, July 26th. The company reported $0.72 earnings per share for the quarter, meeting the Thomson Reuters’ consensus estimate of $0.72. Colgate-Palmolive had a negative return on equity of 10,821.98% and a net margin of 14.77%. The firm had revenue of $3.87 billion during the quarter, compared to the consensus estimate of $3.88 billion. During the same quarter in the previous year, the company posted $0.77 earnings per share. The business’s revenue was down .5% on a year-over-year basis. Equities research analysts predict that Colgate-Palmolive will post 2.84 EPS for the current year.

The firm also recently announced a quarterly dividend, which will be paid on Thursday, August 15th. Investors of record on Thursday, July 18th will be issued a dividend of $0.43 per share. The ex-dividend date is Wednesday, July 17th. This represents a $1.72 dividend on an annualized basis and a dividend yield of 2.42%. Colgate-Palmolive’s dividend payout ratio is presently 57.91%.

Several brokerages have issued reports on CL. Macquarie upped their target price on Colgate-Palmolive from $65.00 to $72.00 and gave the stock a “neutral” rating in a research note on Monday, April 29th. Morgan Stanley boosted their price objective on Colgate-Palmolive from $72.00 to $74.00 and gave the company an “equal weight” rating in a research report on Monday, July 29th. Deutsche Bank boosted their price objective on Colgate-Palmolive from $74.00 to $76.00 and gave the company a “hold” rating in a research report on Friday, July 12th. UBS Group boosted their price objective on Colgate-Palmolive from $80.00 to $82.00 and gave the company a “buy” rating in a research report on Monday, July 29th. Finally, Jefferies Financial Group boosted their price objective on Colgate-Palmolive from $61.00 to $73.00 and gave the company an “in-line” rating in a research report on Monday, April 29th. They noted that the move was a valuation call. One analyst has rated the stock with a sell rating, twelve have issued a hold rating and five have issued a buy rating to the stock. The company presently has an average rating of “Hold” and a consensus price target of $73.13.

In related news, insider Ian M. Cook sold 19,500 shares of the company’s stock in a transaction that occurred on Wednesday, May 29th. The stock was sold at an average price of $69.92, for a total transaction of $1,363,440.00. Following the completion of the transaction, the insider now owns 1,186,042 shares in the company, valued at $82,928,056.64. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. Also, CFO Henning I. Jakobsen sold 33,854 shares of the company’s stock in a transaction that occurred on Wednesday, July 31st. The shares were sold at an average price of $73.45, for a total value of $2,486,576.30. Following the transaction, the chief financial officer now owns 73,693 shares of the company’s stock, valued at approximately $5,412,750.85. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 422,925 shares of company stock valued at $30,478,467. 1.14% of the stock is owned by corporate insiders.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. It offers oral care products, including toothpastes, toothbrushes, and mouthwashes, as well as pharmaceutical products for dentists and other oral health professionals; and personal care products, such as liquid hand soaps, bar soaps, shower gels, deodorants and antiperspirants, skin care products, and shampoos and conditioners.

Featured Article: What is the formula for the cash asset ratio?

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.